Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
暂无分享,去创建一个
Michael D. Burkart | Manfred Rohde | V. Nizet | M. Hensler | J. Pogliano | M. Rohde | P. Nonejuie | M. Burkart | Heriberto Rivera | J. Munguia | Joshua Olson | Ross Corriden | Jason Munguia | Victor Nizet | Ross Corriden | G. Sakoulas | Andrew Hollands | Joshua Olson | George Sakoulas | Joe Pogliano | Poochit Nonejuie | A. Hollands | Mary E. Hensler | Quang Dam | Leo Lin | Monika Kumaraswamy | Heriberto Rivera | M. Kumaraswamy | Leo I. Lin | Q. Dam | Poochit Nonejuie
[1] P. Tulkens,et al. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Kevin Francis,et al. Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model , 2003, Infection and Immunity.
[3] I. Vidavsky,et al. Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma. , 2009, Chest.
[4] T. Sato,et al. A modified method for lead staining of thin sections. , 1968, Journal of electron microscopy.
[5] G. Marshall,et al. The biology and future prospects of antivirulence therapies , 2008, Nature Reviews Microbiology.
[6] P. Honore,et al. Renal and neurological side effects of colistin in critically ill patients , 2011, Annals of intensive care.
[7] K. Iida,et al. Electron microscopic studies on mode of action of polymyxin , 1969, Journal of bacteriology.
[8] M. Hentzer,et al. Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice , 2007, Antimicrobial Agents and Chemotherapy.
[9] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[10] E. Maltezos,et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases , 2011, European Journal of Clinical Pharmacology.
[11] K. Pogliano,et al. Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules , 2013, Proceedings of the National Academy of Sciences.
[12] B. Tümmler,et al. Buccal Adherence of Pseudomonas aeruginosa in Patients with Cystic Fibrosis under Long-Term Therapy with Azithromycin , 2001, Infection.
[13] Steven N. Leonard,et al. Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model , 2012, PloS one.
[14] H. Belzberg,et al. In Vitro Activities of Nontraditional Antimicrobials against Multiresistant Acinetobacter baumannii Strains Isolated in an Intensive Care Unit Outbreak , 2000, Antimicrobial Agents and Chemotherapy.
[15] C. Dolea,et al. World Health Organization , 1949, International Organization.
[16] K. Kannan,et al. Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel , 2012, Cell.
[17] G. H. Gudmundsson,et al. Antimicrobial peptides important in innate immunity , 2011, The FEBS journal.
[18] P. Wayne. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .
[19] Robert E. W. Hancock,et al. Modulating immunity as a therapy for bacterial infections , 2012, Nature Reviews Microbiology.
[20] G. Amsden. Advanced-generation macrolides: tissue-directed antibiotics. , 2001, International journal of antimicrobial agents.
[21] G. Schito,et al. Inhibition of motility ofPseudomonas aeruginosa andProteus mirabilis by subinhibitory concentrations of azithromycin , 1992, European Journal of Clinical Microbiology and Infectious Diseases.
[22] Michael R. Yeaman,et al. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus , 2013, Journal of Molecular Medicine.
[23] V. Nizet,et al. Selectively Guanidinylated Aminoglycosides as Antibiotics , 2012, ChemMedChem.
[24] D. Verbanac,et al. Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin. , 2012, Pharmacological research.
[25] M. Vaara,et al. A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane , 2010, Antimicrobial Agents and Chemotherapy.
[26] Y. Hirakata,et al. Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer Membrane , 2005, Antimicrobial Agents and Chemotherapy.
[27] B. Iglewski,et al. Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation , 2004, Journal of Clinical Microbiology.
[28] V. Nizet,et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] P. McDonald,et al. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum , 1992, Antimicrobial Agents and Chemotherapy.
[30] C. Guzmán,et al. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. , 1993, The Journal of antimicrobial chemotherapy.
[31] L. Hooper,et al. Epithelial antimicrobial defence of the skin and intestine , 2012, Nature Reviews Immunology.
[32] F. Can,et al. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. , 2006, International journal of antimicrobial agents.
[33] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[34] F. Gherardini,et al. A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis , 2012, Front. Cell. Inf. Microbio..
[35] J. Retsema,et al. Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection. , 1990, The Journal of antimicrobial chemotherapy.
[36] D. Rasko,et al. Genome Sequences of Four Divergent Multidrug-Resistant Acinetobacter baumannii Strains Isolated from Patients with Sepsis or Osteomyelitis , 2012, Journal of bacteriology.
[37] William Fenical,et al. Pharmacological Properties of the Marine Natural Product Marinopyrrole A against Methicillin-Resistant Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.
[38] C. Salgado,et al. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria , 2009, Antimicrobial Agents and Chemotherapy.
[39] K. Yanagihara,et al. Azithromycin Attenuates Lung Inflammation in a Mouse Model of Ventilator-Associated Pneumonia by Multidrug-Resistant Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[40] M. Argyres,et al. Hospital-acquired infections due to gram-negative bacteria. , 2010, The New England journal of medicine.
[41] T. Mattila-Sandholm,et al. Fluorometric assessment of Gram‐negative bacterial permeabilization , 2000, Journal of applied microbiology.
[42] R. Bucki,et al. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37 , 2011, Proceedings of the National Academy of Sciences.
[43] D. Zusman,et al. Nucleoid Condensation and Cell Division in Escherichia coli MX74T2 ts52 After Inhibition of Protein Synthesis , 1973, Journal of bacteriology.
[44] R. Hunkler,et al. U.S. outpatient antibiotic prescribing, 2010. , 2013, The New England journal of medicine.
[45] Brian T. Tsuji,et al. Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium , 2011, Antimicrobial Agents and Chemotherapy.
[46] J. Rolain,et al. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[47] J. Rolain,et al. Colistin: an update on the antibiotic of the 21st century , 2012, Expert review of anti-infective therapy.